Hôpital Pasteur

Nice 6000

0 studies enrolling now · 12 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Anemia, Brady Tachy Syndrome, Delayed Graft Function, Multiple Sclerosis, Primary Progressive, Myocardial Infarction, Other Complication of Kidney Transplant, Pompe Disease (Late-onset), Progressive Multiple Sclerosis (PMS), Pulmonary Arterial Hypertension, Relapsing Multiple Sclerosis, Schizophrenia

Studies at this site

• A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
• A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study — Stopped early
• A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease — Completed
• REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension — Completed
• Myocardial Ischemia and Transfusion — Completed
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS — Completed
• QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant — Completed
• I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation — Completed
• Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease — Completed